Ecotrin 81 mg Enteric coated tablet.
PDF Leaflet Revision Date: 02 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
To reduce the risk of myocardial infarction and stroke.
Dosage (summary)
1-3 tablets daily as directed by a doctor.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in first and third trimesters; caution during breastfeeding.
Key Drug Interactions
- Methotrexate >15mg/week
- Anticoagulants
- SSRIs
- Diuretics
Contraindications
- Hypersensitivity to aspirin
- Active peptic ulcer
- Severe hepatic impairment
- Severe renal impairment
Common side effects
- Gastrointestinal disturbances
- Increased bleeding tendencies
- Dyspepsia
Counselling Points
- Take with food to reduce GI upset
- Report unusual bleeding
- Do not exceed recommended dose
Serious warnings
- Risk of Reye's syndrome in children
- Increased risk of bleeding
- Caution before surgery
Important Disclaimer
The Ecotrin 81 mg Enteric coated tablet. professional information leaflet below is the property of Acino Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
